Sophiris Bio (SPHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPHS | ZVSA | BDRX | ||
| Company | Sophiris Bio | Zyversa Therapeutics Inc | Biodexa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.0001 | 1.1200 | 4.71 | ||
| High | 0.0001 | 1.1400 | 4.80 | ||
| Low | 0.0001 | 1.0401 | 3.51 | ||
| Last | 0.0001 | 1.0800 | 3.62 | ||
| Change | unch | -0.0500 | -1.24 | ||
| % Change | unch | -4.42% | -25.51% | ||
| Volume | 1,000 | 115,800 | 66,500 | ||
| 20-Day Average Volume | 47,475 | 3,563,625 | 55,380 | ||
| Previous Close | 0.0001 | 1.1300 | 4.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.0047 | 1.7856 | 5.75 | ||
| 20-Day Raw Stochastic | 0.00% | 1.71% | 2.79% | ||
| 20-Day Relative Strength | 35.47% | 30.48% | 31.99% | ||
| Weighted Alpha | -80.56 | -93.51 | -94.55 | ||
| Today's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 88% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -90.00% since 10/14/21 | -22.86% since 11/08/24 | -32.71% since 11/08/24 | ||
| Low | 0.0001 on 02/14/22 | 1.0401 on 11/15/24 | 3.51 on 11/15/24 | ||
| High | 0.0001 on 02/14/22 | 1.4300 on 11/11/24 | 5.58 on 11/11/24 | ||
| 1-Month | |||||
| %Chg | unch since 12/30/21 | -53.04% since 10/15/24 | -27.74% since 10/15/24 | ||
| Low | 0.0001 on 02/14/22 | 1.0401 on 11/15/24 | 3.51 on 11/15/24 | ||
| High | 0.0001 on 02/14/22 | 3.3700 on 11/05/24 | 10.89 on 10/16/24 | ||
| 3-Month | |||||
| %Chg | unch since 11/05/21 | -64.24% since 08/15/24 | -75.87% since 08/15/24 | ||
| Low | 0.0001 on 02/14/22 | 1.0401 on 11/15/24 | 3.51 on 11/15/24 | ||
| High | 0.0001 on 02/14/22 | 3.9600 on 08/22/24 | 16.31 on 08/20/24 | ||
| 6-Month | |||||
| %Chg | -99.29% since 08/13/21 | -78.14% since 05/15/24 | -87.19% since 05/15/24 | ||
| Low | 0.0001 on 02/14/22 | 1.0401 on 11/15/24 | 3.51 on 11/15/24 | ||
| High | 0.0175 on 09/07/21 | 6.3000 on 07/10/24 | 74.00 on 05/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4 | 1,112 | 431 | ||
| Shares Outstanding, K | 35,550 | 1,029 | 119 | ||
| Annual Sales | 0 | 0 | 410,000 | ||
| Annual Net Income | -6,780,000 | -98,300,000 | -7,660,000 | ||
| Last Quarter Sales | N/A | 0 | N/A | ||
| Last Quarter Net Income | N/A | -2,760,000 | N/A | ||
| 60-Month Beta | N/A | 0.65 | 1.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -3.31 on 08/09/24 | N/A | ||
| Latest Earnings Date | 01/01/21 | 11/12/24 | 04/26/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||